Mylan's Pay for CEO Bresch Grates on Lawmakers, Many Investors 43 minutes ago


Mylan NV Chief Executive Officer Heather Bresch was lambasted at a congressional hearing this week for taking home tens of millions of dollars as the company raised the price on its EpiPen allergy shot. Some investors have been critical of Mylan's executive compensation for years.



from Biotech News